Skip to main content
. 2020 Oct 2;34(6):2447–2453. doi: 10.1111/jvim.15916

TABLE 1.

Frequency and percent occurrence of various characteristics in dogs with Enterococcus or Escherichia coli UTI. The P‐value given assesses overall significance (via likelihood ratio test) of the characteristic among levels of a given categorical factor; estimated odds ratios (Est. OR) show increase (or decrease) in the odds associated with Enterococcus infection for each level of a given factor relative to the indicated reference level, or relative to the geometric mean of the odds (GM odds) for factors with several levels where a definitive reference would otherwise be arbitrary

Characteristic, n (%) P‐value Case (n = 70) Control (n = 70) Est. OR 95% CI
Weight (kg) .59
GM odds = 1.038:1
(4,10] 17 (24.3) 19 (27.1) 0.862 0.483, 1.531
(10,20] 16 (22.9) 10 (14.3) 1.542 0.809, 3.029
(20,30] 17 (24.3) 21 (30.0) 0.780 0.440, 1.371
(30,80] 20 (28.6) 20 (28.6) 0.964 0.552, 1.681
Sex .23
GM odds = 0.700:1
Male/intact 3 (4.3) 6 (8.6) 0.715 0.212, 2.071
Female/intact 6 (8.6) 11 (15.7) 0.780 0.317, 1.829
Female/spayed 54 (77.1) 43 (61.4) 1.795 1.020, 3.250
Male/neutered 7 (10.0) 10 (14.3) 1.000 0.420, 2.334
Other bacteria detected .24
0 39 (55.7) 46 (65.7) Ref
1 27 (38.6) 23 (32.9) 1.385 0.688, 2.807
2 4 (5.7) 1 (1.4) 4.718 0.664, 94.30
Resistance pattern .33
No resistance 20 (28.6) 28 (40.0) Ref
Resistant to 1 class 19 (27.1) 21 (30.0) 1.267 0.544, 2.966
Resistant to 2 classes 12 (17.1) 9 (12.9) 1.867 0.666, 5.396
Resistant to 3+ classes 19 (27.1) 12 (17.1) 2.217 0.891, 5.694
Infection type .04
New infection 26 (39.4) 39 (57.4) Ref
Recurrent 40 (60.6) 29 (42.6) 2.070 1.040, 4.160
Clinical signs of LUTD .21
No 30 (44.8) 24 (34.3) Ref
Yes 37 (55.2) 46 (65.7) 0.640 0.320, 1.280
Antibiotic Tx within 30d before presentation .18
No 44 (63.8) 52 (74.3) Ref
Yes 25 (36.2) 18 (25.7) 1.640 0.800, 3.430
History of urinary catheterization .23
No 56 (84.8) 64 (91.4) Ref
Yes 10 (15.2) 6 (8.6) 1.900 0.660, 5.910
Diabetes mellitus .70
No 67 (95.7) 66 (94.3) Ref
Yes 3 (4.3) 4 (5.7) 0.740 0.140, 3.470
Hyperadrenocorticism 1.00
No 65 (92.9) 65 (92.9) Ref
Yes 5 (7.1) 5 (7.1) 1.000 0.270, 3.750
Steroid treatment .03
No 64 (91.4) 55 (78.6) Ref
Yes 6 (8.6) 15 (21.4) 0.340 0.120, 0.910
Immunosuppressive Tx .44
No 54 (77.1) 50 (71.4) Ref
Yes 16 (22.9) 20 (28.6) 0.740 0.340, 1.580
Kidney disease .77
No 63 (90.0) 64 (91.4) Ref
Yes 7 (10.0) 6 (8.6) 1.190 0.370, 3.870
Uroliths .01
No 54 (81.8) 68 (97.1) Ref
Yes 12 (18.2) 2 (2.9) 7.560 1.950, 49.89
Urinary incontinence .20
No 41 (61.2) 50 (71.4) Ref
Yes 26 (38.8) 20 (28.6) 1.590 0.780, 3.270
LUT neoplasia .04
No 63 (91.3) 69 (98.6) Ref
Yes 6 (8.7) 1 (1.4) 6.570 1.080, 125.9
Ataxia neurologic .32
No 47 (68.1) 53 (75.7) Ref
Yes 22 (31.9) 17 (24.3) 1.460 0.700, 3.100
Ataxia orthopedic .44
No 58 (84.1) 62 (88.6) Ref
Yes 11 (15.9) 8 (11.4) 1.470 0.560, 4.040
Noted LUT anatomic abnormalities .02
No 52 (75.4) 63 (90.0) Ref
Yes 17 (24.6) 7 (10.0) 2.940 1.170, 8.110
USG category .04
GM odds = 1.381:1
(1.000, 1.015] 10 (20.4) 20 (36.4) 0.362 0.143, 0.785
(1.015, 1.030] 21 (42.9) 26 (47.3) 0.585 0.246, 1.175
(1.030, 1.045] 12 (24.5) 8 (14.5) 1.086 0.413, 2.605
(1.045, +++] 6 (12.2) 1 (1.8) 4.345 1.104, 40.05
Proteinuria .12
No 19 (39.6) 30 (54.5) Ref
Yes 29 (60.4) 25 (45.5) 1.830 0.840, 4.060
Hematuria (on dipstick) .61
No 27 (55.1) 33 (60.0) Ref
Yes 22 (44.9) 22 (40.0) 1.220 0.560, 2.680
Pyuria (on sediment) .02
No 22 (46.8) 14 (25.5) Ref
Yes 25 (53.2) 41 (74.5) 0.390 0.170, 0.880
Epithelial cells (on sediment) .61
No 16 (34.0) 21 (38.9) Ref
Yes 31 (66.0) 33 (61.1) 1.230 0.550, 2.810

Abbreviations: LUT, lower urinary tract; LUTD, lower urinary tract disease; Ref, reference value; tx, treatment.